Inactive Instrument

News The Greater Cannabis Company, Inc. Other OTC

Equities

GCAN

US3916571033

Summary

Unlock all the news: Be the first to know and act before the market!

The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 14	CI
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
GCANRx Announces Completion of Preclinical Study for Neuropsychiatric Cannabinoid Therapy	Feb. 27	AQ
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	Nov. 13	CI
GCANRx Featured in American Journal of Endocannabinoid Medicine	23-09-21	AQ
The Greater Cannabis Company, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-14	CI
Nanocap Potential Breakout Watchlist (EPAZ, GCAN, IQST, ONCR)	23-07-06	AQ
GCANRx Announces Approval of Phase II Clinical Trial to Treat Autism Related Spectrum Disorders	23-07-05	AQ
The Greater Cannabis Company, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-12	CI
GREATER CANNABIS COMPANY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-K)	23-04-13	AQ
The Greater Cannabis Company, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-13	CI
The Greater Cannabis Company, Inc. Auditor Raises 'Going Concern' Doubt	23-04-12	CI
Greater Cannabis : Change in Certifying Accountants - Form 8-K	23-01-26	PU
GREATER CANNABIS COMPANY, INC. : Changes in Registrant's Certifying Accountant, Financial Statements and Exhibits (form 8-K)	23-01-26	AQ
GREATER CANNABIS COMPANY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-11-14	AQ
The Greater Cannabis Company, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2022	22-11-14	CI
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders	22-10-07	GL
GCANRx Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders	22-10-07	AQ
Greater Cannabis Company, Inc. Announces Submission of Phase 2 Clinical Trial Application to Treat Autism Related Spectrum Disorders	22-10-07	CI
GREATER CANNABIS COMPANY, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS (form 10-Q)	22-08-15	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News The Greater Cannabis Company, Inc. Other OTC

Equities

GCAN

US3916571033

Summary

Filters